Detection of copy number alterations in cell-free tumor DNA from plasma

Keyphrases

• Copy number Variation 100%
• Circulating Tumor DNA (ctDNA) 100%
• Somatic Copy number Alterations 87%
• Tumor Biopsy 37%
• Targeted Treatment 37%
• Liquid Biopsy 37%
• Clinically Significant 25%
• Aberrations 25%
• SNP Array 25%
• Tumor 12%
• SNP 12%
• High-resolution 12%
• Treatment Course 12%
• Cancer Cells 12%
• Patient Outcomes 12%
• Possible Treatments 12%
• Tumor Classification 12%
• Negative Findings 12%
• Plasma Samples 12%
• Genetic Modification 12%
• Affymetrix 12%
• Sampling Time 12%
• Non-cancer 12%
• Genome Copy number 12%
• Patient Treatment 12%
• Relevant Genes 12%
• Whole Genome 12%
• Biallelic 12%
• Low Correlation 12%
• High Amplitude 12%
• Copy number Profiling 12%
• Metastatic Cancer 12%
• CytoScan 12%
• IncL 12%
• Advanced Scatterometer (ASCAT) 12%
• Liquid Chromatography Analysis 12%
• Apoptosis-necrosis 12%
• DNA Composition 12%
• OncoScan 12%
• Treatment Interference 12%
• Amplitude Amplification 12%
• Tuscan 12%
• T-DNA 12%
• DNA Quality 12%

Medicine and Dentistry

• Circulating Tumor DNA 100%
• Somatics 87%
• Liquid Biopsy 37%
• Tumor Biopsy 37%
• Single Nucleotide Polymorphism 25%
• Programmed Cell Death 12%
• Neoplasm 12%
• Metastatic Carcinoma 12%
• Necrosis 12%
• Targeted Therapy 12%
• Tumor Classification 12%
• False Negative Result 12%
• SNP Array 12%